MarketInOut Stock Screener Log In | Sign Up
 

Lexaria Bioscience Corp

NASDAQ • Healthcare • Biotechnology • Quote as of 05/05/2026 16:00
Lexaria Bioscience Corp stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization17.63 mln
Float23.44 mln
Earnings Date07/14/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.43
Reliable

Relative Strength

2 / 100
Severely lagging

Debt / Equity

0.01
Debt-free

ROE

-175
Deeply negative

Dividend Yield

0.00%
No dividend

Business Description

Lexaria Bioscience Corp. is a Canadian biotechnology company built around its patented DehydraTECH delivery platform, which uses fatty acid-rich oils to help active ingredients absorb into the bloodstream more efficiently. This improved absorption means medications and other compounds can work better at lower doses, making them easier to tolerate. The technology works across a broad range of substances ? from diabetes and weight-loss drugs to vitamins, hormones, and cannabinoids ? and can be applied to everyday product formats such as tablets, capsules, beverages, and foods.

Key Fundamentals

EPS-0.47
ROE-175
RPS0.02
ROIC-1,064
ROA-148
EBITDA, mln-9.38
EV / EBITDA-1.95
EV / EBIT-1.93
Revenue, mln0.37
EV / Revenue49.62

Financial Strength

Altman Z-Score33.42
Piotroski F-Score 5 / 9
Beneish M-Score-3.43
Short Ratio1.98
Short % of Float1.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -21.46% 2 / 100   
1 Month -34.62% 2 / 100   
2 Months -10.91% 26 / 100   
6 Months -32.06% 19 / 100   
1 Year -41.76% 14 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us